Skip to main content
. Author manuscript; available in PMC: 2017 Dec 20.
Published in final edited form as: Med Res Arch. 2017 Mar 15;5(3):10.18103/mra.v5i3.1084. doi: 10.18103/mra.v5i3.1084

Table 3.

Comparing steroids on incidence of infection using time dependent multivariate analysis patients treated with Cyclophosphamide

Type of Infection Number of Events Cumulative Steroid (prednisone mg equivalent) Mean ± STD P value
UTI 0.0240**
Infection n=7 13773.6 ± 7076.4
No Infection n=35 11432.1 ± 5433.6
Pos. Blood Cx 0.0394**
Infection n=2 9010.8 ± 4967.4
No Infection n=40 12021.9 ± 5795.6
Bacterial PNA 0.0247**
Infection n=2 17566.7 ± 11030.9
No Infection 11546.7 ± 5417.2
Pneumocystis carinii PNA 0.0150**
Infection n=1 23305.0 ± 0.0
No Infection n=41 11554.2 ± 5484.9
Mucocutaneous Fungal Infection 0.0544
Infection n=3 8418.3 ± 2392.4
No Infection n=39 12054.8 ± 5822.8
URI 0.0168**
Infection n=13 13649.2 ± 7371.2
No Infection n=29 11039.2 ± 4749.2
Mucocutaneous Bacterial Infection 0.0216**
Infection n=1 18360.0 ± 0.0
No Infection n=41 11678.9 ± 5710.9
Mucocutaneous Viral Infection 0.0113**
Infection n=8 15292.3 ± 5935.1
No Infection n=34 10949.1 ± 5419.5
Viral Gastroenteritis 0.0132**
Infection n=3 17584.4 ± 7008.6
No Infection n=35 11373.1 ± 5457.4
**

Total 42 courses of cyclophosphamide in 31 patients; denominator used is 42.